Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
cross-reactant | substance other than the intended analyte recognized by an assay | The laboratory identified a possible cross-reactant in the immunoassay. | Objective | Drug levels - analyte, specimen and reporting |
lipemia | excess lipid causing a turbid specimen | The laboratory flagged lipemia in the submitted specimen. | Objective | Drug levels - analyte, specimen and reporting |
icterus index | instrument estimate of bilirubin-related specimen discoloration | The icterus index exceeded the assay's stated interference threshold. | Objective | Drug levels - analyte, specimen and reporting |
unit of measure | scale used for a numerical result | The unit of measure on the original concentration is ng/mL. | Objective | Drug levels - analyte, specimen and reporting |
mass concentration | mass of drug per volume of specimen | The mass concentration is reported in mg/L. | Objective | Drug levels - analyte, specimen and reporting |
molar concentration | amount of substance per volume in moles or related units | The molar concentration on the report is expressed in mmol/L. | Objective | Drug levels - analyte, specimen and reporting |
measured concentration | value obtained directly by assay | The measured concentration is recorded separately from the modeled estimate. | Objective | Drug levels - analyte, specimen and reporting |
estimated concentration | value inferred from a model or calculation | The report labels the value as an estimated concentration. | Objective | Drug levels - analyte, specimen and reporting |
corrected concentration | value adjusted mathematically using stated assumptions | The corrected concentration was calculated and is identified separately from the measured value. | Objective | Drug levels - analyte, specimen and reporting |
censored result | inequality reported instead of an exact number | The censored result is recorded as less than 2 mg/L. | Objective | Drug levels - analyte, specimen and reporting |
laboratory flag | annotation applied by the reporting laboratory | A high laboratory flag accompanies the numerical result. | Objective | Drug levels - analyte, specimen and reporting |
critical result | value meeting the reporting laboratory's critical notification policy | The critical result was phoned to the covering clinician. | Objective | Drug levels - analyte, specimen and reporting |
amended result | laboratory result formally revised after initial reporting | The amended result lists the corrected specimen time. | Objective | Drug levels - analyte, specimen and reporting |
steady state | repeated dosing produces a reproducible concentration pattern each interval | Whether steady state was reached is uncertain after the recent regimen change. | Assessment | Drug levels - exposure and pharmacokinetics |
non-steady-state | sample obtained while exposure is still changing between dosing intervals | The team interpreted this as a non-steady-state sample after the dose increase. | Assessment | Drug levels - exposure and pharmacokinetics |
steady-state concentration | concentration at a specified point once repeated-dose exposure has stabilized | The reported steady-state concentration refers to the predose point in the dosing interval. | Assessment | Drug levels - exposure and pharmacokinetics |
therapeutic range | concentration interval used as a treatment reference for a specified context | The applicable therapeutic range depends on the drug, specimen, timing and indication. | Assessment | Drug levels - exposure and pharmacokinetics |
target concentration | patient- or protocol-specific concentration being sought | The transplant team's target concentration is recorded with the specimen type. | Assessment | Drug levels - exposure and pharmacokinetics |
target trough | goal specified for a properly timed predose concentration | The target trough in the current protocol differs from the earlier target. | Assessment | Drug levels - exposure and pharmacokinetics |
target peak | goal specified for a sample meeting the peak protocol | The value was compared with the target peak only after the sampling window was verified. | Assessment | Drug levels - exposure and pharmacokinetics |
within target | falls within the applicable stated goal | The confirmed trough was within target for the goal documented by the treating service. | Assessment | Drug levels - exposure and pharmacokinetics |
above target | exceeds the applicable stated goal | The verified predose level was above target for the documented treatment phase. | Assessment | Drug levels - exposure and pharmacokinetics |
below target | falls below the applicable stated goal | The measured level is below target for the specified sampling window. | Assessment | Drug levels - exposure and pharmacokinetics |
therapeutic window | range of exposure between desired effect and unacceptable toxicity in context | The narrow therapeutic window makes accurate sampling particularly important. | Assessment | Drug levels - exposure and pharmacokinetics |
therapeutic index | measure of separation between effective and toxic doses or exposures | The drug's narrow therapeutic index informs the monitoring plan. | Assessment | Drug levels - exposure and pharmacokinetics |